TY - JOUR
T1 - Multilocus Sequence Typing Reveals Extensive Genetic Diversity of the Emerging Fungal Pathogen Scedosporium aurantiacum
AU - Harun, Azian
AU - Kan, Alex
AU - Schwabenbauer, Katharina
AU - Gilgado, Felix
AU - Perdomo, Haybrig
AU - Firacative, Carolina
AU - Losert, Heidemarie
AU - Abdullah, Sarimah
AU - Giraud, Sandrine
AU - Kaltseis, Josef
AU - Fraser, Mark
AU - Buzina, Walter
AU - Lackner, Michaela
AU - Blyth, Christopher C.
AU - Arthur, Ian
AU - Rainer, Johannes
AU - Lira, José F.Cano
AU - Artigas, Josep Guarro
AU - Tintelnot, Kathrin
AU - Slavin, Monica A.
AU - Heath, Christopher H.
AU - Bouchara, Jean Philippe
AU - Chen, Sharon C.A.
AU - Meyer, Wieland
N1 - Funding Information:
The work was funded by an NHMRC project grant (APP1031943) to WM.
Funding Information:
The authors thank Francoise Symoens (Science Institute of Public Health, Brussels, Belgium), Karen Rogers (Auckland City Hospital, Auckland, New Zealand), and the members of the Australian Scedosporium Study Group (AUSCEDO) for collecting and submitting strains for this study. Members of the Australian Scedosporium Study Group of the Australasian Society for Infectious Diseases (AUSCEDO): ACT: Peter Collignon (The Canberra Hospital); NSW: Richard Benn (Royal Prince Alfred Hospital), Ian Chambers (Douglass Hanly Moir Pathology), Sharon Chen (Westmead Hospital), Nelson Dennis (Wollongong Hospital), Deo DeWit (Gosford Hospital), John Ferguson (John Hunter Hospital), Iain Gosbell (Liverpool Hospital), Thomas Gottlieb (Concord Hospital), Catriona Halliday (Westmead Hospital), Juliette Holland (Mayne Laverty Pathology), Alison Kesson (New Children’s Hospital, Westmead), Richard Lawrence (St. George Hospital), Deborah Marriott (St. Vincent’s Hospital, Sydney), Wieland Meyer (Westmead Hospital), Peter Newton (Wollongong Hospital), Quoc Nguyen (St. Vincent’s Hospital, Sydney), Pamela Palasanthrian (Sydney Children’s Hospital), Robert Pickles (Taree), Robert Pritchard (Royal North Shore Hospital), Tania Sorrell (Westmead Hospital), Lex Tierney (John Hunter Hospital); Voula Tomasotos (Liverpool Hospital), Robert Vaz (Orange Base Hospital); Kerry Weeks (Royal North Shore Hospital). QLD: Anthony Allworth (Royal Brisbane Hospital), Christopher Coulter (The Prince Charles Hospital), Joan Faoagali (Royal Brisbane Hospital), Barbara Johnson (Princess Alexandra Hospital), David Looke (Princess Alexandra Hospital), Joseph McCormack (The Mater Adult Hospital), Graeme Nimmo (Princess Alexandra Hospital), Gabrielle O’Kane (The Prince Charles Hospital), E. Geoffrey Playford (Princess Alexandra Hospital); Jennifer Robson (Sullivan and Nicolaides Pathology); SA: David Ellis (Women’s and Children’s Hospital), Rosemary Handke (Women’s and Children’s Hospital), Karen Rowlands (Royal Adelaide Hospital); David Shaw (Royal Adelaide Hospital); TAS: Louise Cooley (Royal Hobart Hospital), Erica Cox (Launceston General Hospital), Alistair McGregor (Royal Hobart Hospital); VIC: Clare Franklin (Alfred Hospital), Cathy Joseph (St Vincent’s Hospital, Melbourne), Tony Korman (Monash Medical Centre), Orla Morrissey (Alfred Hospital), Monica Slavin (Peter MacCallum Cancer Centre), Denis Spelman (Alfred Hospital), Bryan Speed (Austin and Repatriation Hospitals), Harsha Sheorey (St. Vincent’s Hospital, Melbourne); WA: Western Australia: Peter Boan (Fiona Stanley Hospital (FSH); PathWest Laboratory Medicine, FSH), John Dyer (Fiona Stanley Hospital), Christopher Heath (Fiona Stanley Hospital; PathWest Laboratory Medicine, FSH; & Royal Perth Hospital), Dianne Gardam (PathWest Laboratory Medicine, FSH), Duncan McLennan (Fiona Stanley Hospital), Ronan Murray (Sir Charles Gairdner Hospital, & PathWest Laboratory Medicine, QEII), Todd Pryce (PathWest Laboratory Medicine, FSH), Ian Arthur (PathWest Laboratory Medicine, QEII We thank Krystyna Maszewska for handling the Scedosporium culture collection in the Molecular Mycology Research Laboratory.
Publisher Copyright:
Copyright © 2021 Harun, Kan, Schwabenbauer, Gilgado, Perdomo, Firacative, Losert, Abdullah, Giraud, Kaltseis, Fraser, Buzina, Lackner, Blyth, Arthur, Rainer, Lira, Artigas, Tintelnot, Slavin, Heath, Bouchara, Chen and Meyer.
PY - 2021/12/27
Y1 - 2021/12/27
N2 - Scedosporium spp. are the second most prevalent filamentous fungi after Aspergillus spp. recovered from cystic fibrosis (CF) patients in various regions of the world. Although invasive infection is uncommon prior to lung transplantation, fungal colonization may be a risk factor for invasive disease with attendant high mortality post-transplantation. Abundant in the environment, Scedosporium aurantiacum has emerged as an important fungal pathogen in a range of clinical settings. To investigate the population genetic structure of S. aurantiacum, a MultiLocus Sequence Typing (MLST) scheme was developed, screening 24 genetic loci for polymorphisms on a tester strain set. The six most polymorphic loci were selected to form the S. aurantiacum MLST scheme: actin (ACT), calmodulin (CAL), elongation factor-1α (EF1α), RNA polymerase subunit II (RPB2), manganese superoxide dismutase (SOD2), and β-tubulin (TUB). Among 188 global clinical, veterinary, and environmental strains, 5 to 18 variable sites per locus were revealed, resulting in 8 to 23 alleles per locus. MLST analysis observed a markedly high genetic diversity, reflected by 159 unique sequence types. Network analysis revealed a separation between Australian and non-Australian strains. Phylogenetic analysis showed two major clusters, indicating correlation with geographic origin. Linkage disequilibrium analysis revealed evidence of recombination. There was no clustering according to the source of the strains: clinical, veterinary, or environmental. The high diversity, especially amongst the Australian strains, suggests that S. aurantiacum may have originated within the Australian continent and was subsequently dispersed to other regions, as shown by the close phylogenetic relationships between some of the Australian sequence types and those found in other parts of the world. The MLST data are accessible at http://mlst.mycologylab.org. This is a joined publication of the ISHAM/ECMM working groups on “Scedosporium/Pseudallescheria Infections” and “Fungal Respiratory Infections in Cystic Fibrosis”.
AB - Scedosporium spp. are the second most prevalent filamentous fungi after Aspergillus spp. recovered from cystic fibrosis (CF) patients in various regions of the world. Although invasive infection is uncommon prior to lung transplantation, fungal colonization may be a risk factor for invasive disease with attendant high mortality post-transplantation. Abundant in the environment, Scedosporium aurantiacum has emerged as an important fungal pathogen in a range of clinical settings. To investigate the population genetic structure of S. aurantiacum, a MultiLocus Sequence Typing (MLST) scheme was developed, screening 24 genetic loci for polymorphisms on a tester strain set. The six most polymorphic loci were selected to form the S. aurantiacum MLST scheme: actin (ACT), calmodulin (CAL), elongation factor-1α (EF1α), RNA polymerase subunit II (RPB2), manganese superoxide dismutase (SOD2), and β-tubulin (TUB). Among 188 global clinical, veterinary, and environmental strains, 5 to 18 variable sites per locus were revealed, resulting in 8 to 23 alleles per locus. MLST analysis observed a markedly high genetic diversity, reflected by 159 unique sequence types. Network analysis revealed a separation between Australian and non-Australian strains. Phylogenetic analysis showed two major clusters, indicating correlation with geographic origin. Linkage disequilibrium analysis revealed evidence of recombination. There was no clustering according to the source of the strains: clinical, veterinary, or environmental. The high diversity, especially amongst the Australian strains, suggests that S. aurantiacum may have originated within the Australian continent and was subsequently dispersed to other regions, as shown by the close phylogenetic relationships between some of the Australian sequence types and those found in other parts of the world. The MLST data are accessible at http://mlst.mycologylab.org. This is a joined publication of the ISHAM/ECMM working groups on “Scedosporium/Pseudallescheria Infections” and “Fungal Respiratory Infections in Cystic Fibrosis”.
UR - http://www.scopus.com/inward/record.url?scp=85122747875&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122747875&partnerID=8YFLogxK
U2 - 10.3389/fcimb.2021.761596
DO - 10.3389/fcimb.2021.761596
M3 - Research Article
C2 - 35024355
AN - SCOPUS:85122747875
SN - 2235-2988
VL - 11
JO - Frontiers in cellular and infection microbiology
JF - Frontiers in cellular and infection microbiology
M1 - 761596
ER -